EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The clinical value of hsa-miR-190b-5p in peripheral blood of pediatric β-thalassemia and its regulation on BCL11A expression

Meihuan Chen, Xinrui Wang, Haiwei Wang iD, Min Zhang, Lingji Chen, Hong Chen, Yali Pan, Yanhong Zhang, Liangpu Xu, Hailong Huang iD

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0292031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Meihuan Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Medical Genetic Diagnosis and Therapy Center of Fujian Maternity and Child Health Hospital College of Clinical Medicine for Obstetrics & Gynecology a…. Hauptthemen laut MEDLINE: beta-Thalassemia, MicroRNAs. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Joint Funds for the innovation of science and Technology, Fujian province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The B cell CLL/lymphoma 11A (BCL11A) is a key regulator of hemoglobin switching in β-thalassemia (β-thal). Previous study has suggested that dysregulated microRNAs are involved in the regulation of BCL11A expression. The aim of this study was to investigate the clinical value of hsa-miR-190b-5p in β-thal, and to confirm the regulatory effect of hsa-miR-190b-5p on BCL11A expression.

Methods

The peripheral blood of 25 pediatric β-thal patients and 25 healthy controls were selected, and qRT-PCR was used to analyze the levels of hsa-miR-190b-5p and BCL11A mRNA. The relationship between hsa-miR-190b-5p expression and hematological parameters was assessed by Pearson’s correlation test. The diagnostic power of hsa-miR-190b-5p was evaluated by ROC curves analysis. The direct integration between hsa-miR-190b-5p and BCL11A 3’-UTR was confirmed by luciferase reporter assay.

Results

Hsa-miR-190b-5p expression in pediatric β-thal was upregulated, and negatively correlated with the MCH and HbA levels, but positively correlated with the HbF level. Hsa-miR-190b-5p showed a good diagnostic capability for pediatric β-thal equivalent to that of HbA 2 (AUC: 0.760 vs. 0.758). Moreover, the levels of BCL11A mRNA in pediatric β-thal were decreased, and hsa-miR-190b-5p had a negative correlation with BCL11A mRNA expression ( r = -0.403). BCL11A was a target gene of hsa-miR-190b-5p. The mRNA and protein levels of BCL11A were diminished by introduction of hsa-miR-190b-5p, whereas its expression was upregulated by knockdown of hsa-miR-190b-5p.

Conclusions

Hsa-miR-190b-5p expression was upregulated in pediatric β-thal and might be an effective diagnostic biomarker. BCL11A was negatively regulated by hsa-miR-190b-5p, which might provide new target for the treatment of pediatric β-thal.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta-ThalassemiaMicroRNAsHumansChildTranscription FactorsRNA, MessengerRepressor Proteins

Substanzen

MicroRNAsTranscription FactorsRNA, MessengerBCL11A protein, humanRepressor Proteins

Autor:innen und Institutionen

  • Medical Genetic Diagnosis and Therapy Center of Fujian Maternity and Child Health Hospital College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fujian Provincial Key Labora…
  • Medical Research Center, Fujian Maternity and Child Health Hospital College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou, Fujian, China.
  • School of Pharmacy, Fujian Medical University, Fuzhou, Fujian, China.
  • Medical Technology and Engineering College of Fujian Medical University, Fuzhou, Fujian Province, China.
  • Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian Province, China.

ORCID-Profile: Haiwei Wang, Hailong Huang

Förderung

  • National Natural Science Foundation of China
  • Joint Funds for the innovation of science and Technology, Fujian province

Zitieren

APA

Chen, M., Wang, X., Wang, H., Zhang, M., Chen, L., Chen, H., Pan, Y., Zhang, Y., Xu, L., & Huang, H. (2023). The clinical value of hsa-miR-190b-5p in peripheral blood of pediatric β-thalassemia and its regulation on BCL11A expression. PLOS ONE. https://doi.org/10.1371/journal.pone.0292031

Vancouver

Chen M, Wang X, Wang H, Zhang M, Chen L, Chen H, et al. The clinical value of hsa-miR-190b-5p in peripheral blood of pediatric β-thalassemia and its regulation on BCL11A expression. PLOS ONE. 2023. doi:10.1371/journal.pone.0292031

BibTeX
@article{Chen2023,
  author = {Chen, Meihuan and Wang, Xinrui and Wang, Haiwei and Zhang, Min and Chen, Lingji and Chen, Hong and Pan, Yali and Zhang, Yanhong and Xu, Liangpu and Huang, Hailong},
  title = {The clinical value of hsa-miR-190b-5p in peripheral blood of pediatric β-thalassemia and its regulation on BCL11A expression},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0292031}
}
Kostenlos starten →